ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

BVX Bivictrix Therapeutics Plc

11.50
0.00 (0.00%)
02 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Bivictrix Therapeutics Plc BVX London Acción Ordinaria
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 11.50 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
11.50 11.50 11.50 11.50 11.50
más cotizaciones de acciones »
Sector Industrial de la empresa
PHARMACEUTICALS & BIOTECHNOLOGY

Noticias Recientes

Fecha Hora Fuente Noticia
17/4/202408:23ALNCNewsBivictrix granted FDA orphan drug status for rare cancer..
17/4/202401:00UK RNSBiVictriX Therapeutics PLC Orphan Drug Designation & FDA..
28/3/202402:00UK RNSBiVictriX Therapeutics PLC Grant of Options – PDMR/Director..
04/1/202406:30UKREGBiVictriX Therapeutics PLC Holding(s) in Company
04/1/202406:30UKREGBiVictriX Therapeutics PLC Holding(s) in Company
04/1/202401:00UKREGBiVictriX Therapeutics PLC BiVictriX Hosts Inaugural..
05/12/202305:08UKREGBiVictriX Therapeutics PLC Board Change
30/11/202306:08ALNCNewsIN BRIEF: Bivictrix selects final sequences for lead tumour..
30/11/202301:00UKREGBiVictriX Therapeutics PLC Pipeline update on BVX002
22/11/202311:14UKREGBiVictriX Therapeutics PLC Holding(s) in Company
15/11/202307:05ALNCNewsTRADING UPDATES: BiVictriX patent boost; 4Global deal..
15/11/202301:00UKREGBiVictriX Therapeutics PLC Patent Granted in Japan
12/10/202306:04ALNCNewsBivictrix says BVX001 increases survival rates by more than..
12/10/202301:00UKREGBiVictriX Therapeutics PLC Extended Survival Rates Reported..
03/10/202306:06ALNCNewsBivictrix hires new CFO as Alex Hughes steps down after..
03/10/202301:00UKREGBiVictriX Therapeutics PLC Appointment of Adrian Howd as CFO..
19/9/202311:30ALNCNewsTRADING UPDATES: AEW UK REIT appoints new chair; Oberon..
19/9/202301:00UKREGBiVictriX Therapeutics PLC Interim Results
31/8/202301:00UKREGBiVictriX Therapeutics PLC Total Voting Rights
23/8/202303:30ALNCNewsBivictrix Therapeutics granted US patent for cancer drug..
23/8/202301:00UKREGBiVictriX Therapeutics PLC US Patent Granted
17/8/202301:00UKREGBiVictriX Therapeutics PLC Holding(s) in Company
16/8/202312:00UKREGBiVictriX Therapeutics PLC Holding(s) in Company
11/8/202310:17UKREGBiVictriX Therapeutics PLC Holding(s) in Company
08/8/202311:18UKREGBiVictriX Therapeutics PLC Result of General Meeting
19/7/202313:30ALNCNewsUPDATE: Bivictrix Therapeutics raises GBP2.1 million through..
19/7/202312:16UKREGBiVictriX Therapeutics PLC Result of Conditional Fundraise
19/7/202308:12ALNCNewsIN BRIEF: Bivictrix to raise more than GBP2 million via..
19/7/202306:31UKREGBiVictriX Therapeutics PLC Proposed Fundraise in excess of..
17/7/202307:57ALNCNewsBivictrix Therapeutics hails positive data in final..
17/7/202301:00UKREGBiVictriX Therapeutics PLC Positive final data in..
19/6/202307:50ALNCNewsIN BRIEF: Bivictrix Therapeutics hails positive leukaemia..
19/6/202301:00UKREGBiVictriX Therapeutics PLC Positive interim data
06/6/202307:52ALNCNewsIN BRIEF: Bivictrix selects clinical candidate for leukaemia..
06/6/202301:00UKREGBiVictriX Therapeutics PLC BiVictriX nominates clinical..

Su Consulta Reciente

Delayed Upgrade Clock